Stephen K Doberstein Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Stephen K Doberstein.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Stephen K Doberstein. Stephen K Doberstein is a Chief Scientific Officer in NEKTAR THERAPEUTICS ($NKTR) and a SVP & Chief Scientific Officer in NEKTAR THERAPEUTICS ($NKTR) and a Director in Dicerna Pharmaceuticals Inc ($DRNA).
Address: 201 INDUSTRIAL ROAD SAN CARLOS 94070 CA
Companies in which Stephen K Doberstein is an Insider
Dicerna Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Stephen K Doberstein: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 16 2020
$DRNA Market Capitalization: $50.84M
$DRNA Previous Close: $2.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NEKTAR THERAPEUTICS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Stephen K Doberstein: SVP & Chief Scientific Officer, Chief Scientific Officer
Holdings: 107,668 shares
Current Value: $1,417,988
Latest Transaction: Sep 09 2019
$NKTR Market Capitalization: $2.01B
$NKTR Previous Close: $13.17
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Stephen K Doberstein
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16 2020 | DRNA | Dicerna Pharmaceut ... | Doberstein Stephen K | Director | Option Exercise | A | 21.61 | 15,000 | 324,150 | 15,000 | |
| Jun 16 2020 | DRNA | Dicerna Pharmaceut ... | Doberstein Stephen K | Director | Option Exercise | A | 0.00 | 3,333 | 0 | 3,333 | |
| Mar 16 2020 | DRNA | Dicerna Pharmaceut ... | Doberstein Stephen K | Director | Option Exercise | A | 15.61 | 25,000 | 390,250 | 25,000 | |
| Sep 09 2019 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Buy | P | 17.28 | 15,000 | 259,200 | 107,668 | 92.7 K to 107.7 K (+16.19 %) |
| Aug 19 2019 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Sell | S | 18.15 | 3,245 | 58,897 | 92,668 | 95.9 K to 92.7 K (-3.38 %) |
| May 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Sell | S | 31.37 | 3,461 | 108,572 | 95,913 | 99.4 K to 95.9 K (-3.48 %) |
| Feb 21 2019 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Sell | S | 42.39 | 3,310 | 140,311 | 99,374 | 102.7 K to 99.4 K (-3.22 %) |